4
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0001493152-26-035950
Chief Executive Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ODONNELL FRANCIS E JR Chief Executive Officer | 2026-05-04 | Grant or award | +50,000 | 150,000 | D |
Loading xslF345X06/ownership.xml…